CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $65,000 | -64.1% | 24,371 | -41.6% | 0.00% | – |
| Q4 2021 | $181,000 | -14.2% | 41,761 | +0.9% | 0.00% | – |
| Q3 2021 | $211,000 | -14.9% | 41,408 | +5.6% | 0.00% | – |
| Q2 2021 | $248,000 | -46.3% | 39,199 | -34.5% | 0.00% | – |
| Q1 2021 | $462,000 | -28.5% | 59,820 | -39.4% | 0.00% | – |
| Q4 2020 | $646,000 | -55.9% | 98,661 | -55.2% | 0.00% | -100.0% |
| Q3 2020 | $1,464,000 | -30.1% | 220,132 | -12.5% | 0.00% | -50.0% |
| Q2 2020 | $2,095,000 | – | 251,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |